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Volume 53, Number 17S Abstracts 87Slength, there was no difference in linear elasticity (deforma-
tion 13.3% in tested specimen compared to 12.3% in con-
trol; P0.74). DSC and TMA showed decrease in glass
transition temperature up to 4°C but thermo-tropic tran-
sition was comparable to control.
Conclusions: Simulated physiological in vivo hydrody-
namic fatigue has no significant degradative effect on an
innovative stent-graft from POSS-PCU nanocomposite
polymer. Sutureless technology incorporating nitinol stents
proved to be robust with no separation over accelerated
10-year cycle.
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Objectives: Renal efferent sympathetic nerve overac-
tivity is contributory to the hypertensive state. Guanethi-
dine is known to induce an autonomic denervation through
an immune mediated pathway.We hypothesized that
guanethidine could be safely delivered into the renal peri-
vascular space to produceautonomic denervation and re-
duction in renal norepinephrine (NE) content.
Methods: A micro-infusion catheter (Mercator Med-
Systems) was introduced via the femoral artery into the
renal arteries of (N11) female swin.Two to three ml of
guanethidine (20-30 mg) or vehicle, each with 20% dilu-
tion of contrast, was infused into the adventitial space
under fluoroscopic guidance. The primary efficacy end-
point in this study was kidney NE tissue content measured
by high-performance liquid chromatography.Secondary
outcomes included histological evidence of renal artery
denervation to corroborate efficacy and renal artery injury
and neural inflammation scores.
Results: There were 18 treated renal arteries and 4
vehicle controls in this study.There was 100% procedural
success in the delivery of guanethidine or vehicle to the
renal artery adventitial space.The mean renal artery injury
scores were not different between treated and control pigs
(PNS), and in all cases the endothelial integrity was
maintained.However,in all guanethidine-treated cases
there was histological evidence of peri-neural inflammation
and nerve destruction whereas the nerves appeared normal
in all control animals.There was an overall decrease in renal mortex NE content in a dose dependent fashion, control
4534 ng/g tissue, 20 mg dose 16118 ng/g tissue and
0 mg dose 13316 ng/g tissue, P.038 (Figure).
Conclusions: These data support the hypothesis that
uanethidine can be delivered safely and efficiently into the
enal peri-adventitial space through a novel minimally in-
asive technique.Further, renal NE content is significantly
educed suggesting that this could be a viable procedure in
he treatment of refractory sympathetic-driven hyperten-
ion.
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Objectives: Mesenchymal stem cell (MSC) transplan-
ation is currently being investigated in porcine abdominal
ortic aneurysm (AAA) models for its potential as regener-
tive treatment. Reliable methods of labeling and tracking
SCs are necessary to evaluate their effects. This study
ims to evaluate in vitro performance of Ferex, a superpara-
agnectic iron oxide that can be tracked by magnetic
